# Task Order 3: Interventional Agent Development Services Program

> **NIH NIH N01** · SRI INTERNATIONAL · 2022 · $11,720

## Abstract

The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents. This contract provides for chemistry and manufacturing services under the NIAID Preclinical Services for the Development of Interventional Agents Program.

## Key facts

- **NIH application ID:** 10704968
- **Project number:** 272201100022I-P00015-27200003-3
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** Jon Carl Mirsalis
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $11,720
- **Award type:** —
- **Project period:** 2018-04-17 → 2019-04-16

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10704968

## Citation

> US National Institutes of Health, RePORTER application 10704968, Task Order 3: Interventional Agent Development Services Program (272201100022I-P00015-27200003-3). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10704968. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*